دورية أكاديمية

Unveiling the immune infiltrate modulation in cancer and response to immunotherapy by MIXTURE—an enhanced deconvolution method.

التفاصيل البيبلوغرافية
العنوان: Unveiling the immune infiltrate modulation in cancer and response to immunotherapy by MIXTURE—an enhanced deconvolution method.
المؤلفون: Fernández, Elmer A1 (AUTHOR) efernandez@cidie.ucc.edu.ar, Mahmoud, Yamil D2 (AUTHOR), Veigas, Florencia3 (AUTHOR), Rocha, Darío4 (AUTHOR), Miranda, Matías5 (AUTHOR), Merlo, Joaquín3 (AUTHOR), Balzarini, Mónica6 (AUTHOR), Lujan, Hugo D7 (AUTHOR), Rabinovich, Gabriel A1 (AUTHOR), Girotti, María Romina2 (AUTHOR) efernandez@cidie.ucc.edu.ar
المصدر: Briefings in Bioinformatics. Jul2021, Vol. 22 Issue 4, p1-17. 17p.
مصطلحات موضوعية: CANCER invasiveness, IMMUNOREGULATION, IMMUNOTHERAPY, TUMOR-infiltrating immune cells, PROGRAMMED cell death 1 receptors, IMMUNE checkpoint proteins
مستخلص: The accurate quantification of tumor-infiltrating immune cells turns crucial to uncover their role in tumor immune escape, to determine patient prognosis and to predict response to immune checkpoint blockade. Current state-of-the-art methods that quantify immune cells from tumor biopsies using gene expression data apply computational deconvolution methods that present multicollinearity and estimation errors resulting in the overestimation or underestimation of the diversity of infiltrating immune cells and their quantity. To overcome such limitations, we developed MIXTURE, a new ν-support vector regression-based noise constrained recursive feature selection algorithm based on validated immune cell molecular signatures. MIXTURE provides increased robustness to cell type identification and proportion estimation, outperforms the current methods, and is available to the wider scientific community. We applied MIXTURE to transcriptomic data from tumor biopsies and found relevant novel associations between the components of the immune infiltrate and molecular subtypes, tumor driver biomarkers, tumor mutational burden, microsatellite instability, intratumor heterogeneity, cytolytic score, programmed cell death ligand 1 expression, patients' survival and response to anti-cytotoxic T-lymphocyte-associated antigen 4 and anti-programmed cell death protein 1 immunotherapy. [ABSTRACT FROM AUTHOR]
Copyright of Briefings in Bioinformatics is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Business Source Index
الوصف
تدمد:14675463
DOI:10.1093/bib/bbaa317